Upcoming Research Compound Launch – September 15th

BleauGenics will officially launch a new selection of research compounds on September 15th, 2025. This expansion brings a broader range of high-purity peptides designed to support laboratory research across multiple fields of study.

All compounds are intended for research use only and are not for human or veterinary consumption.

Compounds Launching September 15th

• Retatrutide 10mg (new strength)
• TB-500 5mg
• BPC-157 5mg
• Semaglutide 5mg
• MT-2 10mg
• CJC-1295 (no DAC) 5mg
• MOTS-c 10mg
• Semax 10mg
• Selank 10mg
• Epitalon 10mg

Why This Launch Matters

With this expansion, researchers gain access to additional compounds for metabolic, regenerative, and cognitive studies. By continuing to provide research-grade precision and transparency, BleauGenics remains committed to supporting scientific discovery.

Launch Date

These compounds will be available starting September 15th, 2025 through our online catalog.